0 CHECKOUT

Ukrainian pharmaceuticals: Darnitsa

  • ID: 683158
  • October 2007
  • Region: Ukraine
  • 43 pages
  • Concorde Capital
1 of 3

The Ukrainian pharmaceutical market has been growing at 32% CAGR over 2004-2006. We expect it to double by 2010 to USD 75 per capita, moving toward the Eastern European average of USD 140. Still, operating margins in the Ukrainian pharmaceutical sector re

Note: Product cover images may vary from those shown
2 of 3

TABLE OF CONTENTS

1. INVESTMENT CASE
BUSINESS PROFILE
Executive summary
Valuation summary

5. Ukrainian Pharmaceutical Market

Underpenetrated, double growth by 2010
Product mix: Generics and OTC prevail
Competition
Market drivers
Higher consumer incomes

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Pfizer Inc.
  • Grünenthal GmbH
  • GlaxoSmithKline PLC
  • Abbott Laboratories Ltd.
  • Roche Diagnostics Ltd.
  • Novo Nordisk A/S